Abstract We have previously described an immortal rat central-nervous-system progenitor cell line, AF5, which is able to exit the cell cycle and assume a differentiated state with neuronal properties. The phenotypic specification of differentiated AF5 cells, however, is not known. In the present study, when induced to differentiate by serum starvation in Neurobasal medium, AF5 cells down-regulate glial fibrillary acidic protein and up-regulate expression of β-IIItubulin, medium-molecular-weight neurofilament protein, and neuronal growth-associated protein 43. Expression of the gamma-aminobutyric acid (GABA) lineage marker, glutamic acid decarboxylase 67 (GAD67), increases during differentiation, suggesting that AF5 cells adopt a GABAergic lineage. Time-course analysis of the GABAergic neuron specification transcription factor, Pitx2, by reverse transcription/polymerase chain reaction, has shown an increase in the Pitx2 transcript 48 h after initiation of differentiation. In differentiated AF5 cells, expression of the Pitx2 target gene products GAD65 and GABA transporter-1 increases. Cellular GABA levels in differentiated AF5 cells increase by about 26-fold, and GABA release into the medium is 150-fold higher compared with that of undifferentiated cells. Therefore, AF5 cells can be induced to differentiate to a neuronal phenotype with a GABAergic lineage.
Introduction
Multipotent central-nervous-system (CNS) progenitor cells are potentially useful for in vitro developmental studies and for in vivo cell-based therapies such as neural transplantation. AF5 cells are a CNS-derived cell line immortalized from primary fetal rat mesencephalic cells with an N-terminal fragment of the SV40 large T antigen (Truckenmiller et al. 1998 ). These cells retain plasticity similar to primary neural stem cells, i.e., they proliferate as adherent cultures in an undifferentiated state when passaged at regular intervals, yet retain the ability to exhibit neuronal properties when allowed to become confluent and remain undisturbed for several weeks (Truckenmiller et al. 2002) . This passive differentiation methodology does not, however, lend itself to experimental paradigms in order that the developmental properties of AF5 cells can be exploited. In addition, the ability to exhibit neuronal properties is not unique, as many other immortal cell lines also retain such potential, especially after transplantation into the brain (FrickerGates et al. 2004; Shihabuddin et al. 1995; Renfranz et al. 1991; Snyder et al. 1992; Conzen and Cole 1995; Colby and Shenk 1982; Clayton et al. 1982) . However, few neural cell lines have the capacity to manifest lineage-specific functionality during in vitro culture. Cell lines that have the ability to differentiate and develop into neuronal cells with a consistent lineage in culture would provide a useful in vitro model for the study of neuronal development and phenotype-specific differentiation.
Gamma-aminobutyric acid (GABA) has multiple functions in the nervous system including roles as a neurotransmitter, neurotrophin, and metabolite (Waagepetersen et al. 1999 ). In the CNS, GABA is the primary inhibitory neurotransmitter. As a neurotrophic agent, GABA plays a regulatory role during cell differentiation and early development, and as a metabolite, it is a component of the GABA shunt of the tricarboxylic acid cycle. GABA is synthesized from glutamic acid by glutamic acid decarboxylase (GAD), which exists in two isoforms, GAD65 and GAD67. GAD65 is specific to GABAergic function; it is believed to maintain the pool of GABA in nerve terminals and is activated in response to increasing demand for the neurotransmitter. In contrast, GAD67 is constitutively expressed and synthesizes cytosolic GABA for nonvesicular release or metabolic purposes (Pinal and Tobin 1998) . Expression of both isoforms of GAD and the GABA vesicular transporter, GAT-1, are coordinated by the homeodomain transcription factor, Pitx2 (Eastman et al. 1999) . Recent studies have demonstrated the role of Pitx2 in midbrain neuron development and GABAergic neuron specification (Westmoreland et al. 2001a,b; Martin et al. 2002 Martin et al. , 2004 .
Several cell lines exist that either inherently or through genetic manipulation express GAD67 and produce GABA in vitro (Giordano et al. 1993 (Giordano et al. , 1996 Eaton et al. 1999; Conejero-Goldberg et al. 2000) . Whereas cell lines can also be manipulated to over-express GAD65 Thompson et al. 2000) , little has been reported regarding inherent GAD65 expression or putative GABAergic function for immortalized cell lines during neuronal differentiation. Promoter studies have been performed in the P19 embryonic carcinoma line (Pinal et al. 1997) , and GAD65 expression has been reported in human fibroblasts and in neuroectodermal and insulinoma cell lines (Kono et al. 2001; Salazar et al. 2001; Varju et al. 2002) . The neuronal cell line NTera-2N is negative for GAD65 mRNA (Yoshioka et al. 1997) , and although PC12 cells have been found to modulate GAD65 and GAD67 expression in response to hypoxia, they are not otherwise GABAergic (Kobayashi and Millhorn 2001) . In the present study, we describe the propensity of an immortal non-transformed rat mesencephalic cell line, AF5, to differentiate in response to high-confluence culture conditions and serum-starvation, to express GABA specific Pitx2 target genes, and to exhibit neuronal and GABAergic lineage-specific properties.
Materials and methods

Cell culture
The AF5 cell line has been previously described (Truckenmiller et al. 1998 (Truckenmiller et al. , 2002 . The cells were maintained in a 5% CO 2 incubator in Dulbecco's modified Eagle's medium/Ham's F12 (DMEM/F12, 1:1; Gibco Life Technologies, Gaithersburg, Md.) medium containing 10% fetal calf serum (FCS), 2 mM L-glutamine, 100 U/ml penicillin G, and 100 μg/ml streptomycin. Differentiation medium consisted of Neurobasal medium supplemented with serum-free human B27 (Neurobasal/B27 medium; Gibco Life Technologies). To induce differentiation, AF5 cells were grown to 100% confluence and maintained undisturbed in complete medium for 1-3 weeks or changed to Neurobasal/B27 medium and further incubated for 2-4 days as indicated. AF5 cells were also incubated for 2 days in Neurobasal/B27 medium supplemented with 50 μM dibutyryl cyclic AMP (dbcAMP; Sigma-Aldrich, St. Louis, Mo.). Additional conditions tested included growth on neuritogenic BioCoat substrates including poly-D/L-lysine, ornithine/laminin, collagen, and fibronectin (Becton Dickinson, Franklin Lakes, N.J.) in combination with either serum-containing or serum-free DMEM/F12 medium, anti-proliferative agents (50 μM dbcAMP, 10 nM retinoic acid; Sigma), or various combinations of cell-cycle blockers (100 μM Lmimosine, 1.5 μM aphidicolin, 500 μM deferoxamine; Sigma). In addition, AF5 cells were co-cultured with primary neural cultures including E15-derived rat astrocytes or cortical neurons. In some experiments, morphological observations were assessed by using AF5 cells following transient transfection of the pTG plasmid encoding an enhanced green fluorescent protein (EGFP)-Tau fusion protein (kind gift of Drs. B. Hoffer and A. Tomac, NIDA), by using FuGene6 (Roche Applied Science, Indianapolis, Ind.) according to the manufacturer's suggested protocol.
Quantitative real-time reverse transcription/ polymerase chain reaction Total RNA was extracted from AF5 cultures by using RNA STAT-60 (TEL-TEST, Friendswood, Tex.); 2 μg (in 2 μl) of the total RNA was reverse-transcribed to cDNA by a reaction containing 5 μl first strand buffer, 5 μl 10 mM dNTP mix, 1 μl 25 μM oligo (dT) 15, 0.5 μl RNase inhibitor (20 U/25 μl), and 1.0 μl Moloney murine leukemia virus reverse transcriptase (100 U/25 μl). The reaction was performed at 42°C for 1 h, followed by heating at 75°C for 10 min, and then cooling to 4°C. To quantify the expression of Pitx2, we applied quantitative real-time reverse transcription/polymerase chain reaction (PCR) by using a DNA Engine Opticon Fluorescence Detection System (MJ Research, Waltham, Mass.) in a total reaction volume of 20 μl containing SYBR Green PCR master mix, essentially according to the manufacturer's protocol. The primer sequences and size of the PCR product for Pitx2 were as follows: sense CAAATGGAG AAAGCGGGAGC, antisense ATGGATGAGATGGAGT TGGGCG, 246 bp. PCR was performed as follows: 95°C for 10 min for initial denaturation, followed by 40 cycles of denaturation at 95°C for 30 s, annealing at 55°C for 30 s, and extension at 72°C for 30 s. The results were analyzed by using Opticon software. Relative expression was calibrated by normalizing to 18S ribosomal RNA (Ambion, Austin, Tex.) with 1.0 for the control.
Immunocytochemistry
Cells were immunostained as previously described (Truckenmiller et al. 1998) . Briefly, adherent cells were fixed with ice-cold 4% paraformaldehyde or 100% ethanol at room temperature for 10 min. Following three washes with phosphatebuffered saline (PBS), non-specific binding was blocked for 1 h in blocking buffer (10% normal goat serum and 0.1% bovine serum albumin). The cells were incubated overnight at 4°C with primary antibody (anti-β-III-tubulin at 1:1,000, Promega, Madison, Wis.; anti-GAD65 at 1:100 or anti-GAD67 at 1:1,000, Chemicon, Temecula, Calif.; anti-nestin at 1:1,000, Pharmingen, San Diego, Calif.) diluted in blocking buffer. After three washes with PBS, the cells were incubated with secondary antibodies (anti-rabbit or anti-mouse Alexa Fluor 594 at 1:500, Molecular Probes, Ore.) diluted in blocking buffer and washed. Some wells were counter-stained with 4,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) to stain nuclei. The cells were covered with Slow Fade Light mounting solution (Molecular Probes) and viewed with a Zeiss Axiovert inverted microscope with appropriate filters. Images were captured by using a Photometrics Cool Snap digital camera and IPLab software.
Immunoblot analysis
Lysates of cells cultured under undifferentiated or differentiated conditions were processed to isolate either cytosolic or membrane fractions. Lysate protein concentrations were estimated by using a modified Bradford assay (BioRad), and equal amounts of each sample were fractionated by SDS-polyacrylamide gel electrophoresis and electroblotted onto nitrocellulose membranes. Blots containing cytosolic proteins were probed for GAD67 (Santa Cruz Biotechnologies, Santa Cruz, Calif.; 1:1,000), β-IIItubulin (Promega, Madison, Wis.; 1:1,000), glial fibrillary acidic protein (GFAP; DAKO, Carpinteria, Calif.; 1:1,000), neuronal growth-associated protein 43 (GAP43; Santa Cruz; 1:2,000), medium-molecular-weight neurofilament protein (NF-M; Chemicon; 1:1,000), or α-tubulin (Sigma-Aldrich) overnight at 4°C. Blots containing cellular membrane fractions were similarly probed for GAD65 (Chemicon; 1:1,000) or GAT-1 (Chemicon; 1:1,000). Appropriate horseradish-peroxidase-conjugated secondary antibodies (BioRad) were used at a dilution of 1:3,000, and blots were developed by using chemiluminescent detection methods (Santa Cruz Biotechnologies). GABA assays AF5 cells were grown to sub-confluence in DMEM/F12 medium (undifferentiated) or 24 h or 48 h post-confluence in Neurobasal/B27 medium with 10% FCS. Lysates were harvested by scraping following the addition of a solution consisting of 0.1% Triton X-100 and 30 mM HEPES, pH 7.2. GABA levels in the lysates and culture medium were measured by high-pressure liquid chromatography (HPLC) by using o-phthalaldehyde-sulfite derivatization (Jacobs 1987) . GABA levels were normalized to total cellular protein measured by using the BCA assay.
Statistical analysis
All values are expressed as means ± standard error of the mean (SEM). Groups were compared by using analysis of variance (ANOVA) followed by post-hoc tests for individual comparisons. The criterion for statistical significance was P<0.05.
Results
Differentiating conditions
A number of culture conditions, including treatment with mitotic inhibitors or neurotrophins, in combination with several neuritogenic substrates, induced partial differentiation with incomplete commitment toward neuronal phenotypes, as measured by changes in neuron-specific protein expression. Poly-D/L-lysine, ornithine/laminin, collagen, and fibronectin in combination with serum-free medium, anti-proliferative agents (50 μM dbcAMP, 10 nM retinoic acid), or various combinations of cell-cycle blockers (Lmimosine, aphidicolin, deferoxamine) did not produce consistent differentiation (data not shown). In the presence of the anti-proliferative agent, dbcAMP, AF5 cells ceased dividing and extended short processes; however, no neuronal marker expression was detectable (data not shown). A morphological change was noted when AF5 cells were co-cultured with astrocytes isolated from E15 embryonic rat (Fig. 1a-c) , but this was neither accompanied by neuron-associated protein expression nor consistently reproducible. Co-culture of AF5 cells with rat cortical neurons occasionally resulted in up-regulation of the neuron-specific marker β-III-tubulin; however, this was not associated with any morphological change, including neurite extension or a decrease in the ratio of cytosolic to nuclear volume (see Fig. 1e,f) .
The two treatment regimens that produced the most consistent differentiation were: (1) maintenance of the cells for several weeks under confluent conditions, as previously described (Truckenmiller et al. 2002) , or (2) incubation of the cells in serum-free Neurobasal/B27 medium, with or without the addition of the anti-proliferative agent, dbcAMP (Fig. 2) . Growth in Neurobasal/B27 medium for 4 days stimulated a morphological change including Fig. 2 Phenotypic changes in AF5 cells. a, b Cells transiently transfected with a plasmid vector encoding EGFP-tau fusion protein (green) and cultured under normal proliferative conditions or incubated in Neurobasal/B27 for 4 days. This resulted in morphological changes including neurite extension and cytosolic compaction. c Cells (blue DAPI staining) under proliferative conditions expressed high levels of nestin protein (red). d The number of cells that were nestin-positive decreased on Neurobasal/B27 incubation supplemented with dbcAMP for 48 h; nuclei were counterstained with DAPI (blue). e, f A 48-h treatment in Neurobasal/B27/dbcAMP also modulated both cellular morphology and GAD67 expression (red). g Cells under logarithmic growth conditions were negative for GAD65, but (h) when allowed to grow undisturbed in complete medium for 1 week, began to express GAD65 (red); nuclei were counterstained with DAPI (blue). ×32 (a-d, f and g), ×20 (e and h) decreased cytosolic volume and neuritogenesis (Fig. 2a,b) . Addition of dbcAMP resulted in decreased nestin expression, increased GAD67 expression, some neurite extension, and cytosolic compaction (Fig. 2c-f ). Long-term maintenance at high confluence decreased nestin and increased β-III-tubulin expression, as previously described (Truckenmiller et al. 2002) , in addition to stimulating the expression of GAD65 (Fig. 2g,h) . Therefore, the phenotypic analysis of differentiating AF5 cells was carried out by using growth to confluence followed by culture in Neurobasal/B27 medium alone.
Neuronal and GABAergic marker expression
Immunoblot analysis was performed for cultures either passaged every 3 days (proliferating) or allowed to become confluent and switched to Neurobasal/B27 medium for 4 days (differentiated). In differentiated cultures, GFAP was decreased, whereas β-III-tubulin, neuronal GAP43 and NF-M were increased (Fig. 3a) .
Proliferating AF5 cells expressed basal levels of GAD67. When differentiated, however, GAD67 was markedly up-regulated (Fig. 3b) . Nevertheless, GAD67 expression is also found in other neural subtypes, including glia, and is not necessarily indicative of commitment to a GABAergic lineage.
GABA-specific transcription factor Pitx2 and target gene expression A significant increase was noted in Pitx2 transcription as AF5 cells differentiated in Neurobasal/B27 medium (Fig. 4a) . The increase in the Pitx2 transcript was transient, peaking at 48 h and attenuating by 4 days, consistent with its role as a developmentally regulated transcription factor. AF5 cells were also tested for expression of two Pitx2 target genes, GAD65 and GAT-1. Proliferating undifferentiated AF5 cells were negative for GAD65 and contained low levels of GAT-1 protein but became GAD65-positive and markedly up-regulated GAT-1 after differentiation for 4 days (Fig. 4b) .
GABA production Undifferentiated AF5 cells under log-phase growth conditions contained trace levels of intracellular GABA (approximately 0.5 nmol/mg protein). GABA levels increased approximately 26-fold in differentiated cells treat- Fig. 4 AF5 cells modulated the GABAergic-specific Pitx2 transcription factor and target protein expression. a Real-time PCR timecourse analysis was carried out on AF5 cells under normal proliferating conditions, growth to confluence, or after differentiation for 2 and 4 days in Neurobasal/B27 medium (2d NB and 4d NB, respectively). A significant increase (asterisk) in Pitx2 transcription factor mRNA was detected 2 days after induction of differentiation. b AF5 cells were incubated to sub-confluence in DMEM/F12 medium (log growth) or in Neurobasal/B27 medium post-confluence for 4 days (differentiated). Immunoblot analysis showed that GAD65 protein was undetectable in AF5 cells during logarithmic growth in DMEM/F12 medium and accumulated during differentiation. AF5 cells contained basal levels of GAT-1, which was upregulated in response to differentiating conditions. The analysis of α-tubulin indicated protein loading ed with fresh Neurobasal/B27 medium for 24 h (Fig. 5a ). Intracellular GABA was also elevated at 48 h post-differentiation but was diminished as compared with 24 h, perhaps because of increased GABA efflux. The increase in intracellular GABA was not attributable to the media change, as no GABA increase was observed in undifferentiated cells exposed to fresh DMEM/F12, even after 48 h. GABA efflux levels into the medium of differentiated AF5 cells after 24 h and 48 h in fresh Neurobasal/B27 medium attained levels of >150-fold that of undifferentiated AF5 cells (Fig. 5b) . Again, this effect was not a result of the medium change, as undifferentiated cells treated with fresh DMEM/F12 medium for 48 h did not excrete appreciable amounts of GABA into the medium (<2 nmol/mg protein).
Discussion
AF5 cells expressed a GABAergic phenotype when confluent and incubated in a neuronal supportive medium, viz., Neurobasal/B27. Under these conditions, AF5 cells downregulated neuronal precursor and glial-specific markers and up-regulated neuron-specific protein expression. They also expressed proteins specific for GABAergic neuronal function and produced GABA.
Neural precursor cells have previously been reported to differentiate in vitro to GABAergic phenotypes (Carpenter et al. 1999; Reynolds et al. 1992) . Indeed, the GABAergic phenotype has been suggested as being the "default" differentiation pathway for neuronal precursor cells (Sah et al. 1997; Jain et al. 2003) . In nearly all of these cases, however, GABAergic lineage has been defined either by the expression of GAD67 or the presence of GABA immunoreactivity, which is not thought to indicate synaptic GABAergic function. In contrast, the AF5 cell line can be readily induced to differentiate in a manner that results in the expression of a relatively complete GABAergic phenotype, including the expression of Pitx2, GAD65, GAD67, and GAT-1 and the production of GABA.
Currently, few relevant cell lines are suitable for in vitro diagnostic and/or in vivo therapeutic use, as the majority of studies have been performed in either tumor cell lines requiring supra-physiological treatments to differentiate or primary cells requiring extensive manipulation and subculturing techniques to yield consistent results (Trojanowski et al. 1997; Vaudry et al. 2002) . Since AF5 progenitor cells are stable in vitro (Truckenmiller et al. 2002) and can be readily induced to undergo GABAergic differentiation in vitro, these cells may provide a useful in vitro tool for studies of GABAergic neuronal differentiation and neurodegenerative/neurocognitive disease models related to GABAergic function.
